17. Zytiga
Typical cost for a 30-day supply: $15,400
Treats: Prostate cancer
A form of chemotherapy approved by the FDA in 2011, Zytiga can extend the life of late-stage prostate cancer patients by several months. Last year it generated more than $2 billion in revenue for owner Johnson & Johnson.
